Lloyd Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Lloyd Advisory Services's BMY Position: Q2 2026 in Review
Lloyd Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2026, selling an estimated $804 and leaving 48 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #475.
Lloyd Advisory Services first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $572K in Q3 2023. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Lloyd Advisory Services held 48 shares of Bristol-Myers Squibb worth $2.76K as of Q2 2026.
- Lloyd Advisory Services sold 14 Bristol-Myers Squibb shares in Q2 2026, an estimated $804.
- Bristol-Myers Squibb made up ﹤0.01% of Lloyd Advisory Services's portfolio in Q2 2026, its #475 holding.
- Lloyd Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
- Lloyd Advisory Services's Bristol-Myers Squibb position peaked at $572K in Q3 2023.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.